Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
To potentially enhance the bioavailability and therapeutic efficacy of an existing pharmaceutical regimen
3 In REDEFINE 1, CagriSema produced 22.7% weight loss compared with 16.1% for semaglutide alone (the drug in Wegovy) over 68 weeks
2021, doi: 10.1038/s41598-021-83932-4
Commercial success will increasingly depend on licensed coverage across states, prior-authorization support and transparent pharmacy routing
US$ 22.59
US$ 28.42
US$ 26.47
US$ 28.56
US$ 29.74
US$ 20.24
